We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Defective Lipoprotein Binding in the Brain Linked to Alzheimer's Disease Risk

By LabMedica International staff writers
Posted on 03 Aug 2016
Mutations in the TREM2 (Triggering receptor expressed on myeloid cells 2) gene, which encodes a protein expressed selectively by microglia in the brain, have been linked to disrupted binding of lipoproteins and are associated with the development of Alzheimer’s disease (AD). More...


Previous studies had shown that microglia - immune cells that remove pathogenic materials from the brain in a manner similar to that of microphages in the immune system - from individuals with TREM2 mutations had decreased ability to bind to lipoproteins in the brain's extracellular milieu.

To study this phenomenon further, investigators at the biotech company Genetech (South San Francisco, CA, USA) performed a large unbiased screen of an extracellular recombinant protein library representing 1,559 extracellular proteins and identified a set of lipoprotein particles and apolipoproteins as ligands of TREM2.

They reported in the July 20, 2016, issue of the journal Neuron that the TREM2 ligands included the apolipoproteins APOE and CLU (APOJ), which are risk genes for AD, and that their binding was impaired by TREM2 mutations that conferred AD risk. Binding of these ligands by TREM2 was abolished or reduced by disease-associated mutations.

Overexpression of wild-type TREM2 was sufficient to enhance uptake of LDL, CLU, and APOE in heterologous cells, whereas TREM2 disease variants were impaired in this activity. Amyloid-beta was found to be bound to lipoproteins, and this complex was efficiently taken up by microglia in a TREM2-dependent fashion. Uptake of Amyloid-beta-lipoprotein complexes was reduced in macrophages from human subjects carrying a TREM2 AD variant. In addition, the investigators provided evidence that, through its interaction with lipoproteins, TREM2 could facilitate Amyloid-beta uptake by microglia and human macrophages.

"I think we are only scratching the surface of what TREM2 does," said senior author Dr. Morgan Sheng, vice-president of neuroscience at Genentech. "Lipoproteins float around in the blood, and their purpose is to carry cholesterol or lipids from one cell to another - as we all know, too much LDL is associated with high cholesterol and increased risk of cardiovascular disease. Lipoproteins also exist in the brain, but less is understood about their role there. "

"Overall, these studies further point towards microglia as playing an important role in the pathogenesis of Alzheimer's disease," said Dr. Shen. "It was a surprise that amyloid-beta was much more efficiently engulfed when bound in a lipoprotein complex, rather than when amyloid-beta aggregates were free and naked."

Related Links:
Genetech



New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
Gold Member
Collection and Transport System
PurSafe Plus®
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.